N C Armitage

1.0k total citations
33 papers, 661 citations indexed

About

N C Armitage is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N C Armitage has authored 33 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N C Armitage's work include Colorectal Cancer Screening and Detection (13 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). N C Armitage is often cited by papers focused on Colorectal Cancer Screening and Detection (13 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). N C Armitage collaborates with scholars based in United Kingdom and United States. N C Armitage's co-authors include J D Hardcastle, J Chamberlain, S S Amar, J H Scholefield, Alan C. Perkins, T.W. Balfour, P. S. Rooney, Peter James, R W Baldwin and J D Hardcastle and has published in prestigious journals such as The Lancet, Cancer and Gut.

In The Last Decade

N C Armitage

31 papers receiving 610 citations

Peers

N C Armitage

ONCOL

PFM

PRM

SURGE

RNMI

Vittoria Stigliano Italy

Luigi Salvagno Italy

J Faintuch United States

Nicola Borsellino Italy

M. Bonsignori Italy

Madhavan V. Pillai United States

S Jelić Serbia

J. Bishop Australia

Anne-Marie Ruppert France

Jean‐Nicolas Munck France

Vittoria Stigliano Italy

N C Armitage

334 ×0.7

ONCOL

315 ×1.6

PFM

106 ×0.5

PRM

125 ×0.8

SURGE

55 ×0.5

RNMI

Citations per year, relative to N C Armitage N C Armitage (= 1×) peers Vittoria Stigliano

Countries citing papers authored by N C Armitage

Since Specialization

Citations

This map shows the geographic impact of N C Armitage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N C Armitage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N C Armitage more than expected).

Fields of papers citing papers by N C Armitage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N C Armitage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N C Armitage. The network helps show where N C Armitage may publish in the future.

Co-authorship network of co-authors of N C Armitage

This figure shows the co-authorship network connecting the top 25 collaborators of N C Armitage. A scholar is included among the top collaborators of N C Armitage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N C Armitage. N C Armitage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robinson, M.H., J D Hardcastle, Sue Moss, et al.. (1999). The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 45(4). 588–592. 81 indexed citations

Armitage, N C, et al.. (1998). Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. British Journal of Cancer. 78(10). 1346–1349. 61 indexed citations

Hunt, Lesley, P. S. Rooney, J D Hardcastle, & N C Armitage. (1998). Endoscopic screening of relatives of patients with colorectal cancer. Gut. 42(1). 71–75. 26 indexed citations

Willsher, Peter C., J.F.R. Robertson, N C Armitage, et al.. (1996). Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women. European Journal of Surgical Oncology. 22(1). 34–37. 8 indexed citations

Armitage, N C, et al.. (1995). The effect of calcium supplements on rectal mucosal proliferation. British Journal of Cancer. 71(1). 186–190. 17 indexed citations

Sibbering, D.M., A P Locker, J D Hardcastle, & N C Armitage. (1994). Blood transfusion and survival in colorectal cancer. Diseases of the Colon & Rectum. 37(4). 358–363. 23 indexed citations

Rooney, P. S., et al.. (1993). The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). British Journal of Cancer. 68(1). 172–175. 13 indexed citations

Rooney, P. S., M.H. Robinson, Philip A. Clarke, J D Hardcastle, & N C Armitage. (1993). Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation. British journal of surgery. 80(2). 249–251. 10 indexed citations

Jones, H, et al.. (1989). Development of an ELISA to detect early local relapse of colorectal cancer. British Journal of Cancer. 60(4). 533–537. 2 indexed citations

10.

Ellis, Ian O., et al.. (1989). Differential expression of the lewis Y antigen defined by monoclonal antibody C14/1/46/10 in colonic polyps. Cancer. 64(2). 414–421. 13 indexed citations

11.

Ballantyne, K C, Alan C. Perkins, M. V. Pimm, et al.. (1988). Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer. International Journal of Cancer. 41(S2). 103–108. 18 indexed citations

12.

Pye, Geoffrey W., K C Ballantyne, N C Armitage, & J D Hardcastle. (1987). Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.. BMJ. 294(6586). 1510–1511. 18 indexed citations

13.

Pimm, M. V., N C Armitage, K C Ballantyne, et al.. (1987). Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates.. PubMed. 1. 249–62. 5 indexed citations

14.

Durrant, LG, R. A. Robins, Alan C. Perkins, et al.. (1986). Antigenicity of newly established colorectal carcinoma cell lines. British Journal of Cancer. 53(1). 37–45. 26 indexed citations

15.

Armitage, N C. (1986). The localization of anti-tumour monoclonal antibodies in colorectal cancer.. PubMed. 68(6). 302–6. 2 indexed citations

16.

Armitage, N C, Alan C. Perkins, LG Durrant, et al.. (1986). In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen. British journal of surgery. 73(12). 965–969. 16 indexed citations

17.

Armitage, N C & J D Hardcastle. (1985). Screening for colorectal cancer.. PubMed. 11(4). 327–32. 3 indexed citations

18.

Hardcastle, J D, N C Armitage, J Chamberlain, T.W. Balfour, & S S Amar. (1985). A control trial of faecal occult blood screening for colorectal cancer: 2-year results. British journal of surgery. 72(Supplement_1). s69–s71. 9 indexed citations

19.

Price, Michael R., M. V. Pimm, Christian M. Page, et al.. (1984). Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen. British Journal of Cancer. 49(6). 809–812. 8 indexed citations

20.

Hardcastle, J D & N C Armitage. (1984). Early Diagnosis of Colorectal Cancer: A Review. Journal of the Royal Society of Medicine. 77(8). 673–676. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact